Agios Share Price

Agios Share Price

NASDAQ: AGIO | Small Cap | Healthcare
$27.60
-$1.14 (-3.97%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Agios Stock Performance

Open
$28.15
Prev. Close
$28.74
Circuit Range
N/A
Day Range
$27.45 - $28.90
Year Range
$23.05 - $44.07
Volume
48,361
Average Traded
$27.94

Agios Share Price Today

As of 21 November 2026, Agios Pharmaceuticals, Inc.'s share price is $27.60. The stock opened at $28.15, compared to its previous close of $28.74. During today's trading session, Agios Pharmaceuticals, Inc.'s share price traded between $27.45 and $28.90, with an average price of $28.17. Over the past 52 weeks, the stock has recorded a high of $44.07 and a low of $23.05. In terms of performance, Agios Pharmaceuticals, Inc.'s share price has declined by 6.11% over the last six months and is down 5.45% on a year-on-year basis.

Agios Share Price Chart

Line chart of the Agios price trend over the selected period. The price fell overall, ranging from 27.45 to 29.04, ending at 27.60.
$27.45$28.90
L
Show Current Price
H

Agios Stock Fundamentals & Key Indicators

Market Cap
$1.60B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-6.23
Revenue (TTM)
$54.03B
Return On Equity (TTM)
-38.08%
Profit Margin
-763.98%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
39.79%

Agios Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$19.97$20.75$44.75$55.39
Net Profit-$108.04-$99.11-$100.70-$65.05
Net Profit Margin-541.01%-477.64%-225.03%-117.44%
Income ChangeN/A8.27%-1.60%35.40%

Agios Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$14.24$26.82$36.50$54.03
Net Profit-$231.80-$352.09$673.73-$412.78
Net Profit Margin-1627.81%-1312.79%1845.84%-763.98%
Income ChangeN/A-51.89%291.35%-161.27%

Agios Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets355.17697.6103.28405.95
Current Assets942.05965.6833.84832.77
Total Assets1297.231663.2937.121238.72
Non Current Liabilities21.9141.0958.1475.28
Current Liabilities82.2181.1667.9662.63
Total Liabilities104.11122.24126.1137.9
Shareholders' Equity1193.111540.96811.021100.81

Agios Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-372.98-389.84-296.06-309.48
Investing377.18363.44239.58243.26
Financing8.6814.445.432.35

About Agios

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Agios Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$30.82
$27.53
-9.86%
Oct 2026
$33.55
$30.54
-8.37%
Sep 2026
$33.70
$33.33
-2.81%
Aug 2026
$30.13
$34.30
+14.41%
Jul 2026
$37.17
$29.98
-19.22%
Jun 2026
$29.04
$37.10
+26.23%
May 2026
$28.02
$29.39
+5.00%
Apr 2026
$33.89
$28.00
-17.25%
Mar 2026
$29.25
$33.83
+11.95%
Feb 2026
$27.88
$30.22
+10.05%
Jan 2026
$27.18
$27.46
+0.84%
Dec 2025
$28.54
$27.23
-6.71%

Agios Share Price FAQs